• IMMUNE NETWORK
• /
• 제3권2호
• /
• pp.110-117
• /
• 2003

Background: The usefulness of DNA vaccine at priming step of heterologous prime-boost vaccination led to DNA vaccine closer to practical reality. DNA vaccine priming followed by recombinant viral vector boosting via systemic route induces optimal systemic immunity but no mucosal immunity. Mucosal vaccination of the reversed protocol (recombinant viral vector priming-DNA vaccine boosting), however, can induce both maximal mucosal and systemic immunity. Here, we tried to address the reason why the mucosal protocol of prime-boost vaccination differs from that of systemic vaccination. Methods: To address the importance of primary immunity induced at priming step, mice were primed with different doses of DNA vaccine or coadministration of DNA vaccine plus mucosal adjuvant, and immunity including serum IgG and mucosal IgA was then determined following boosting with recombinant viral vector. Next, to assess influence of humoral pre-existing immunity on boosting $CD8^+$ T cell-mediated immunity, $CD8^+$ T cell-mediated immunity in B cell-deficient (${\mu}K/O$) mice immunized with prime-boost regimens was evaluated by CTL assay and $IFN-{\gamma}$-producing cells. Results: Immunity primed with recombinant viral vector was effectively boosted with DNA vaccine even 60 days later. In particular, animals primed by increasing doses of DNA vaccine or incorporating an adjuvant at priming step and boosted by recombinant viral vector elicited comparable responses to recombinant viral vector primed-DNA vaccine boosted group. Humoral pre-existing immunity was also unlikely to interfere the boosting effect of $CD8^+$ T cell-mediated immunity by recombinant viral vector. Conclusion: This report provides the important point that optimally primed responses should be considered in mucosal immunization of heterologous prime-boost regimens for inducing the effective boosting at both mucosal and systemic sites.

• Clinical and Experimental Pediatrics
• /
• 제52권6호
• /
• pp.649-654
• /
• 2009

The immune system is comprised of cells and molecules whose collective and coordinated response to the introduction of foreign substance is referred to as the immune response. Defense against microbes is mediated by the early reaction (innate immunity) and the late response (adaptive immunity). Innate immunity consists of the epithelial barrier, phagocytes, complement and natural killer cells. Adaptive immunity, a more complex defense reaction, consists of activation of later-developed lymphocytes that, when stimulated by exposure to infectious agents, increase in magnitude and defensive capabilities with each successive exposure. In this review we discuss recent advances in important primary immune deficiency disorders of innate immunity (chronic granulomatous disease, leukocyte adhesion deficiency) and adaptive immunity (severe combined immune deficiency, Wiskott- Aldrich syndrome).

• Clinical and Experimental Pediatrics
• /
• 제53권12호
• /
• pp.985-988
• /
• 2010

The innate immune response is the first line of defense against microbial infections. Innate immunity is made up of the surface barrier, cellular immunity and humoral immunity. In newborn, immunologic function and demands are different to adults. Neonatal innate immunity specifically suppresses Th1-type immune responses, and not Th2-type immune responses, which are enhanced. And the impaired response of macrophages is associated with the defective innate immunity in newborn period. Toll-like receptors (TLRs) play a key roles in the detection of invading pathogens and in the induction of innate immune responses. In newborn, the expression of TLRs is age dependent, so preterm has low expression of TLRs. Also, there are defects in signaling pathways downstream of TLRs. As a consequence, the defects of TLRs activity cause the susceptibility to infection in the neonatal period.

• Journal of Digestive Cancer Research
• /
• 제6권1호
• /
• pp.11-15
• /
• 2018

Chemotherapy and surgical resection are the mainstay of cancer treatment. Particularly for chemotherapy, although it is effective method to care, sometimes cure various cancers, there are many different status of cancer not being controlled by chemotherapy such as recurrence and resistance to chemotherapy. In order to overcome those difficulties during cancer therapy, immunotherapy targeting immune cells and immune associated factors to enhance cancer immunity has been highlighted. Innate immunity plays important roles on initial stage of cancer immunity that are detecting, killing cancer cells and initiating adaptive immunity for cancer. So many basic and clinical studies to manage innate immunity for cancer therapy have been going on, and most of them were to stimulate innate immune cells including dendritic cell, macrophage, monocyte, and natural killer cell in various ways. They showed promising results but still there are many things to be resolved before clinical application. Herein, I review the role of innate immune cells and therapeutic trials for colorectal cancer.

• 자동차안전학회지
• /
• 제11권4호
• /
• pp.50-56
• /
• 2019

Recently, automobile industries have developed ADAS, smart cars, connected cars, automated driving systems, which use a variety of sensor systems - ultrasonics, cameras, lidars and radars - and communication systems. It is necessary to examine the electromagnetic immunity of vehicles equipped with those systems. The electromagnetic immunity tests are carried out in an electromagnetic semi anechoic chamber, which is cut off from the outside. It is difficult to create test environments in which the radar sensor systems of vehicles work properly in the test chamber. In this study, test jigs were designed and tested and as a result they are shown to be effective to create test environments for electromagnetic immunity tests of vehicles equipped with radar sensors. We also proposed additional safety standards for immunity tests of vehicles with radar systems that currently do not exist.

• 자동차안전학회지
• /
• 제12권4호
• /
• pp.7-12
• /
• 2020

Recently, automobile industries have developed ADAS, smart cars, connected cars, automated driving systems, which use a variety of sensor systems - ultrasonics, cameras, lidars and radars - and communication systems. It is necessary to examine the electromagnetic immunity of vehicles equipped with the sensor systems due to the fact that the normal operation of those systems is very important to the safety of the vehicles. The electromagnetic immunity tests are carried out in an electromagnetic semi anechoic chamber, which is cut off from the outside. It is difficult to create test environments in which the camera sensor systems of vehicles work properly in the test chamber. In this study, test jigs were designed and tested and as a result they are shown to be effective to create test environments for electromagnetic immunity tests of vehicles equipped with camera sensors. We also proposed additional safety standards for immunity tests of vehicles with camera systems that currently do not exist.

• Journal of electromagnetic engineering and science
• /
• 제11권4호
• /
• pp.274-281
• /
• 2011

High-speed telecommunication systems are influenced by electromagnetic environments because they need a wide bandwidth to transmit signals. Immunity tests of telecommunication equipment are effective for improving its immunity to electromagnetic environments. However, immunity tests are expensive to carry out because there are several different tests. The correlation among the tests should therefore be examined in order to reduce the kinds of tests that are necessary. This paper investigates the correlation between the electrical fast transient/burst (EFTB) test and the radio frequency (RF) conductive immunity test. Imitation equipment was constructed with a balun, and a baseband signal was transmitted from the associated equipment to the imitation equipment. Then, disturbances were applied to the equipment, and the telecommunication quality was evaluated by using the bit error rate (BER). The results from the EFTB test indicated that the BER was less than $6{\times}10^{-5}$ and the value was independent of the peak value. The results from the RF conductive immunity test indicated that the BER was affected by the longitudinal conversion loss (LCL).

• IMMUNE NETWORK
• /
• 제22권5호
• /
• pp.38.1-38.24
• /
• 2022

Exosomes, which are well-known nanoscale extracellular vesicles, are multifunctional biomaterials derived from endosomes and perform various functions. The exosome is a critical material in cell-cell communication. In addition, it regulates the pathophysiological conditions of the tumor microenvironment in particular. In the tumor microenvironment, exosomes play a controversial role in supporting or killing cancer by conveying biomaterials derived from parent cells. Innate immunity is a crucial component of the host defense mechanism, as it prevents foreign substances, such as viruses and other microbes and tumorigenesis from invading the body. Early in the tumorigenesis process, the innate immunity explicitly recognizes the tumor via Ags and educates the adaptive immunity to eliminate it. Recent studies have revealed that exosomes regulate immunity in the tumor microenvironment. Tumor-derived exosomes regulate immunity against tumor progression and metastasis. Furthermore, tumor-derived exosomes regulate polarization, differentiation, proliferation, and activation of innate immune cells. Exosomes produced from innate immune cells can inhibit or support tumor progression and metastasis via immune cell activation and direct cancer inhibition. In this study, we investigated current knowledge regarding the communication between tumor-derived exosomes and innate immune cell-derived exosomes (from macrophages, dendritic cells, NK cells, and neutrophils) in the tumor microenvironment. In addition, we discussed the potential development of exosomal immunotherapy using native or engineered exosomes against cancer.

• 한국진공학회:학술대회논문집
• /
• 한국진공학회 2013년도 제45회 하계 정기학술대회 초록집
• /
• pp.92.2-92.2
• /
• 2013

The design and chemical synthesis of multifunctional nanomaterials have been providing potential applications in biomedical fields such as molecular imaging and drug delivery. Recently, bio-derived and/or synthetic nanostructured materials capable of modulating the immune system have been also issues of interest in immunology-related nanomedicine fields. In this talk, the recent research results on the development of nanostructured materials for enhanced immunity would be presented. I will introduce the chemical strategy for the combination of nanostructured materials and bioactive compounds to improve both anti-cancer immunity and vaccine delivery efficiency.

• 한국잠사학회:학술대회논문집
• /
• 한국잠사학회 2002년도 Join Meetings of Korean Society of Sericultural Science and Japanse Society of Sericultural Science
• /
• pp.73-73
• /
• 2002

No Abstract, See Full Text